EZH2 and cancer: Therefore, the Y641N or Y641S mutations in the EZH2 SET domain do not affect EZH2 protein levels, but result in a hyperactive enzyme causing aberrantly increased H3K27me3 in the EZH2GOF DLBCL cells compared to other cancer cell lines.